Literature DB >> 31499964

Carbon nanotube/iron oxide hybrid particles and their PCL-based 3D composites for potential bone regeneration.

Małgorzata Świętek1, Antonín Brož2, Jacek Tarasiuk3, Sebastian Wroński3, Waldemar Tokarz3, Agata Kozieł4, Marta Błażewicz4, Lucie Bačáková5.   

Abstract

This study describes the preparation, and evaluates the biocompatibility, of hydroxylated multi-walled carbon nanotubes (fCNTs) functionalized with magnetic iron oxide nanoparticles (IONs) creating hybrid nanoparticles. These nanoparticles were used for preparing a composite porous poly(ε-caprolactone) scaffolds for potential utilization in regenerative medicine. Hybrid fCNT/ION nanoparticles were prepared in two mass ratios - 1:1 (H1) and 1:4 (H4). PCL scaffolds were prepared with various concentrations of the nanoparticles with fixed mass either of the whole nanoparticle hybrid or only of the fCNTs. The hybrid particles were evaluated in terms of morphology, composition and magnetic properties. The cytotoxicity of the hybrid nanoparticles and the pure fCNTs was assessed by exposing the SAOS-2 human cell line to colloids with a concentration range from 0.01 to 1 mg/ml. The results indicate a gradual increase in the cytotoxicity effect with increasing concentration. At low concentrations, interestingly, SAOS-2 metabolic activity was stimulated by the presence of IONs. The PCL scaffolds were characterized in terms of the scaffold architecture, the dispersion of the nanoparticles within the polymer matrix, and subsequently in terms of their thermal, mechanical and magnetic properties. A higher ION content was associated with the presence of larger agglomerates of particles. With exception of the scaffold with the highest content of the H4 nanoparticle hybrid, all composites were superparamagnetic. In vitro tests indicate that both components of the hybrid nanoparticles may have a positive impact on the behavior of SAOS-2 cells cultivated on the PCL composite scaffolds. The presence of fCNTs up to 1 wt% improved the cell attachment to the scaffolds, and a content of IONs below 1 wt% increased the cell metabolic activity.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biocompatibility; CNT; Composite scaffold; Hybrid nanoparticles; Iron oxide; Polycaprolactone

Mesh:

Substances:

Year:  2019        PMID: 31499964     DOI: 10.1016/j.msec.2019.109913

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  6 in total

1.  [Advantages and challenges of carbon nanotubes as bone repair materials].

Authors:  Yixing Ren; Ruoyu Huang; Cunyang Wang; Yajie Ma; Xiaoming Li
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-03-15

2.  Magnetic Temperature-Sensitive Solid-Lipid Particles for Targeting and Killing Tumor Cells.

Authors:  Małgorzata Świętek; Rostyslav Panchuk; Nadia Skorokhyd; Peter Černoch; Nataliya Finiuk; Olha Klyuchivska; Martin Hrubý; Matúš Molčan; Walter Berger; Jirí Trousil; Rostyslav Stoika; Daniel Horák
Journal:  Front Chem       Date:  2020-04-09       Impact factor: 5.221

Review 3.  Advances in Biodegradable 3D Printed Scaffolds with Carbon-Based Nanomaterials for Bone Regeneration.

Authors:  Sara Lopez de Armentia; Juan Carlos Del Real; Eva Paz; Nicholas Dunne
Journal:  Materials (Basel)       Date:  2020-11-11       Impact factor: 3.623

Review 4.  Paramagnetic Functionalization of Biocompatible Scaffolds for Biomedical Applications: A Perspective.

Authors:  Simona Bettini; Valentina Bonfrate; Ludovico Valli; Gabriele Giancane
Journal:  Bioengineering (Basel)       Date:  2020-11-28

Review 5.  Carbon nanomaterials for drug delivery and tissue engineering.

Authors:  Shaolie Zheng; Yuan Tian; Jiang Ouyang; Yuan Shen; Xiaoyu Wang; Jian Luan
Journal:  Front Chem       Date:  2022-09-12       Impact factor: 5.545

Review 6.  Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics.

Authors:  Mónica Cerqueira; Efres Belmonte-Reche; Juan Gallo; Fátima Baltazar; Manuel Bañobre-López
Journal:  Pharmaceutics       Date:  2022-02-25       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.